Isracann Biosciences will manage the Israeli Cannabis Project

Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ATLED) is an Israel-based company focused on becoming a leading low-cost, high-quality cannabis producer for both domestic and European export. The company has contracted LinC to prepare a formal strategic project description for the successful development of its planned 230,000 square foot dedicated production facility.

Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ATLED) is an Israel-based company focused on becoming a leading low-cost, high-quality cannabis producer for both domestic sales and European export.

The project description, for which the company has contracted LinC to Growing Smart Ltd. to prepare it, is a comprehensive and detailed document describing the site’s specific seasonal climate conditions. 

This includes daily sunshine hours, average daily/nightly maximum and minimum temperatures, daily humidity and UV index values. 

With this information, the project description determines the necessary climate controls and equipment for the greenhouse for dehumidification, air circulation, shading, active heating, cooling and carbon dioxide enrichment.

LinC is the cannabis specialist division of Grow Smart Ltd with offices in Tel Aviv, Israel and Shanghai, and China. The company is an international agricultural project management company that provides turnkey projects to the cannabis sector and delivers tailor-made solutions to the unique needs of each project.

Since 2006, Israel has authorized therapeutic cannabis consumption, which can be prescribed in controlled doses for patients with cancer, epilepsy, post-traumatic stress disorder or degenerative diseases. That is why more and more companies begin to enter the sector.

Laws and rules relating to cannabis around the world change quickly. These new industries are difficult to navigate but hemp investing apps like Hemp.im provide some clarity and can help prospective investors understand the market. 

LinC commissioned to provide agronomic cannabis services for Isracann

In addition to developing the project description for Isracann, LinC was commissioned to provide site-specific agronomic cannabis services. 

LinC’s agronomy team is led by Tal Saadon, who holds a Master of Science degree in agronomy. 

Saadon also has over ten years of experience in commercial agriculture, particularly greenhouse cannabis growing, from sowing to harvesting and drying techniques, to extensive work experience with multiple growers and the various departments of the Ministry of Health.

The team also includes Tal Tregerman, a second-generation farmer from a founding family of an important agricultural Moshav (cooperative) in the productive Negev region. 

Tregerman originally founded IMC Ltd, one of the first successful outdoor cannabis greenhouses in Israel, clearly demonstrating his ability to develop farm concepts into successful ongoing operations.

LinC’s team works with producers, entrepreneurs, investors, agricultural research centres, agricultural technology companies and input companies across the industry. This work reflects more than 20 years of direct experience benefiting the medical cannabis industry in Israel and abroad. 

The company’s role extends well beyond the initial planning phase and includes technical, business, construction and financial solutions, as well as continuous knowledge transfer and support throughout the lifecycle of Isracann’s production facility.

__

(Featured image by K Ch via Unsplash)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Hemp.im, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in DGAP, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.